Acorda Therapeutics reported $46M in Current Liabilities for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acadia Pharmaceuticals ACAD:US $ 119.6M 23.54M
Acorda Therapeutics ACOR:US $ 46M 8.02M
Agios Pharmaceuticals AGIO:US $ 45.79M 14.03M
ALKERMES ALKS:US $ 462.36M 8.93M
Amgen AMGN:US $ 12886M 702M
Anika Therapeutics ANIK:US $ 26.99M 2.8M
Aptinyx Inc APTX:US $ 4.74M 949K
Arrowhead Research ARWR:US $ 138.86M 1.82M
Biogen BIIB:US $ 3946.6M 351.6M
Biomarin Pharmaceutical BMRN:US $ 490.42M 49.4M
Cara Therapeutics CARA:US $ 18.3M 680K
Clovis Oncology CLVS:US $ 121.83M 3.38M
Cytokinetics CYTK:US $ 66.85M 5.01M
Enanta Pharmaceuticals ENTA:US $ 30.74M 7.15M
Gilead Sciences GILD:US $ 8558M 3052M
GlaxoSmithKline GSK:LN 24278M 608M
Halozyme Therapeutics HALO:US $ 111.69M 5.46M
Heron Therapeutics HRTX:US $ 93M 21.94M
Insmed INSM:US $ 125.25M 9.92M
Ligand Pharmaceuticals LGND:US $ 42.58M 0.91M
Mannkind MNKD:US $ 53.49M 5.14M
Merck MRK:GR € 10207M 225M
Moderna Inc MRNA:US 9.24B 110M
Neurocrine Biosciences NBIX:US $ 253.5M 7.7M
Novartis NOVN:VX SF 29807M 401M
Pfizer PFE:US $ 39268M 3403M
Teva Pharmaceutical TEVA:IT 11.61B 586M
Ultragenyx Pharmaceutical RARE:US $ 167.23M 14.14M
Vertex Pharmaceuticals VRTX:US $ 2180.2M 38.2M